产品
编 号：F554764
分子式：C37H44BrO4P
分子量：663.62
分子式：C37H44BrO4P
分子量：663.62
产品类型
规格
价格
是否有货
5mg
询价
询价
10mg
询价
询价
25mg
询价
询价
50mg
询价
询价
100mg
询价
询价
结构图
CAS No: 1254044-38-6
产品详情
生物活性：
Mito-apocynin (C11), an orally active mitochondria-targeted triphenylphosphonium (TPP)-based compound, is synthesized by conjugating the Apocynin moiety with a TPP+ cation. Mito-apocynin (C11) selectively targets mitochondria, and shows neuroprotective effect. Mito-apocynin (C11) prevents hyposmia and corrects deficits in motor function.
体内研究：
Mito-apocynin-C11 (3 mg/kg；口服强饲；3 次/周，从 3 个月大到 15 个月) 显著改善 LRRK2R1441G 小鼠的协调运动功能和嗅觉功能。Animal Model:LRRK2R1441G mice
Dosage:3 mg/kg
Administration:Oral gavage; 3x/wk from 3 months of age until 15 months
Result:Markedly improved the coordinated motor function and olfactory function.
Mito-apocynin (C11), an orally active mitochondria-targeted triphenylphosphonium (TPP)-based compound, is synthesized by conjugating the Apocynin moiety with a TPP+ cation. Mito-apocynin (C11) selectively targets mitochondria, and shows neuroprotective effect. Mito-apocynin (C11) prevents hyposmia and corrects deficits in motor function.
体内研究：
Mito-apocynin-C11 (3 mg/kg；口服强饲；3 次/周，从 3 个月大到 15 个月) 显著改善 LRRK2R1441G 小鼠的协调运动功能和嗅觉功能。Animal Model:LRRK2R1441G mice
Dosage:3 mg/kg
Administration:Oral gavage; 3x/wk from 3 months of age until 15 months
Result:Markedly improved the coordinated motor function and olfactory function.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备